Ivan Spasojevic, PhD

Publications

Tovmasyan, A, Maia, CGC, Weitner, T, Carballal, S, Sampaio, RS, Lieb, D, Ghazaryan, R, Ivanovic-Burmazovic, I, Ferrer-Sueta, G, Radi, R, Reboucas, JS, Spasojevic, I, Benov, L, and Batinic-Haberle, I. "A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeutics." Free Radical Biology & Medicine 86 (September 2015): 308-321.

PMID
26026699
Full Text

Mook, RA, Wang, J, Ren, X-R, Chen, M, Spasojevic, I, Barak, LS, Lyerly, HK, and Chen, W. "Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure." Bioorganic & Medicinal Chemistry 23, no. 17 (September 2015): 5829-5838.

PMID
26272032
Full Text

Bhattacharyya, J, Bellucci, JJ, Weitzhandler, I, McDaniel, JR, Spasojevic, I, Li, X, Lin, C-C, Chi, J-TA, and Chilkoti, A. "A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models." Nature Communications 6 (August 4, 2015): 7939-null.

PMID
26239362
Full Text

Batinic-Haberle, I, Tovmasyan, A, and Spasojevic, I. "An educational overview of the chemistry, biochemistry and therapeutic aspects of Mn porphyrins--From superoxide dismutation to H2O2-driven pathways." Redox Biology 5 (August 2015): 43-65. (Review)

PMID
25827425
Full Text

Friese, CR, McArdle, C, Zhao, T, Sun, D, Spasojevic, I, Polovich, M, and McCullagh, MC. "Antineoplastic drug exposure in an ambulatory setting: a pilot study." Cancer Nursing 38, no. 2 (March 2015): 111-117.

PMID
24831047
Full Text

Friese, CR, McArdle, C, Zhao, T, Sun, D, Spasojevic, I, Polovich, M, and McCullagh, MC. "Antineoplastic drug exposure in an ambulatory setting: A pilot study." Cancer Nursing 38, no. 2 (January 1, 2015): 111-117.

Full Text

Weitzel, DH, Tovmasyan, A, Ashcraft, KA, Rajic, Z, Weitner, T, Liu, C, Li, W, Buckley, AF, Prasad, MR, Young, KH, Rodriguiz, RM, Wetsel, WC, Peters, KB, Spasojevic, I, Herndon, JE, Batinic-Haberle, I, and Dewhirst, MW. "Radioprotection of the brain white matter by Mn(III) n-Butoxyethylpyridylporphyrin-based superoxide dismutase mimic MnTnBuOE-2-PyP5+." Molecular Cancer Therapeutics 14, no. 1 (January 2015): 70-79.

PMID
25319393
Full Text

Halvorson, KG, Barton, KL, Schroeder, K, Misuraca, KL, Hoeman, C, Chung, A, Crabtree, DM, Cordero, FJ, Singh, R, Spasojevic, I, Berlow, N, Pal, R, and Becher, OJ. "A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent." Plos One 10, no. 3 (January 2015): e0118926-null.

PMID
25748921
Full Text

Il'yasova, D, Wagenknecht, LE, Spasojevic, I, Watkins, S, Bowden, D, Wang, F, and D'Agostino, RB. "Urinary F2-isoprostanes and metabolic markers of fat oxidation." Oxidative Medicine and Cellular Longevity 2015 (January 2015): 729191-null.

PMID
25802683
Full Text

Tovmasyan, A, Babayan, N, Poghosyan, D, Margaryan, K, Harutyunyan, B, Grigoryan, R, Sarkisyan, N, Spasojevic, I, Mamyan, S, Sahakyan, L, Aroutiounian, R, Ghazaryan, R, and Gasparyan, G. "Novel amphiphilic cationic porphyrin and its Ag(II) complex as potential anticancer agents." Journal of Inorganic Biochemistry 140 (November 2014): 94-103.

PMID
25086237
Full Text

Pages